Join to View Full Profile
1665 Aurora CtAurora, CO 80045
Phone+1 720-848-0000
Dr. Angelos is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Mathew Angelos, MD, is an Oncologist based in Philadelphia, PA. He completed his medical education at the University of Minnesota Medical School in 2018 and his residency in Internal Medicine at Hospital of the University of Pennsylvania (2018 - 2020). A prolific publisher, Dr. Angelos's significant works include a first-in-human study on a novel anti-CD19 chimeric antigen receptor T cell product, as well as compelling articles in the fields of T-Cell Lymphomas treatment. His publications, broadly cited, appear in noted journals such as Blood, Molecular Cancer, Transplantation and Cellular Therapy, Journal of Personalized Medicine, Current Opinion in Hematology, and Stem Cells.
Education & Training
University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2020 - 2024- University of Pennsylvania Health SystemResidency, Internal Medicine, 2018 - 2020
University of Minnesota Medical SchoolClass of 2018
Certifications & Licensure
CO State Medical License 2024 - 2025
PA State Medical License 2021 - 2024
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 1 citationsEZH1/EZH2 inhibition enhances adoptive T cell immunotherapy against multiple cancer models.Patrizia Porazzi, Siena Nason, Ziqi Yang, Alberto Carturan, Guido Ghilardi
Cancer Cell. 2025-03-10 - 2 citationsCAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial.Kim A Reiss, Mathew G Angelos, E Claire Dees, Yuan Yuan, Naoto T Ueno
Nature Medicine. 2025-02-07 - 1 citationsThe Society for Immunotherapy of Cancer Perspective on Tissue-Based Technologies for Immuno-Oncology Biomarker Discovery and Application.Anne Monette, Adriana Aguilar-Mahecha, Emre Altinmakas, Mathew G Angelos, Nima Assad
Clinical Cancer Research. 2025-02-03
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
